[logo] HealthTree Foundation
search person

Enhanced and Expanded AI-Powered Personalized Clinical Trial Finder

Posted: Sep 19, 2025
Enhanced and Expanded AI-Powered Personalized Clinical Trial Finder image

This Blood Cancer Awareness Month, we are announcing enhancements to our multiple myeloma AI-powered Personalized Clinical Trial Finder and an expansion of the tool to include all blood cancers.

Enhancements to the tool include automated AI calculation of prior lines of therapy from patient medical records—an essential eligibility requirement that is difficult to determine from standard electronic health records. Additional improvements deliver higher perfect-match rates, clearer matching explanations and a patient feedback mechanism.

The HealthTree Clinical Trial Finder is now available for all blood cancers, including lymphomas, leukemias, and myeloproliferative neoplasms (MPNs).

This new feature uses artificial intelligence to match patients to clinical trials based on their individual medical records, increasing their chances of accessing cutting-edge therapies currently in development.

For many patients, finding an appropriate clinical trial can be an overwhelming and time-consuming process. Trial eligibility criteria are complex, and manually searching through hundreds of open trials is nearly impossible. Our Personalized Clinical Trial Finder streamlines this process by analyzing each patient's unique medical data—including lab values, treatment history, and disease markers—against the eligibility criteria of every available trial. The result is a curated list of trials for which the patient qualifies, helping them and their care teams make informed decisions about participation.

"This is the first truly personalized clinical trial finder," said Jenny Ahlstrom, HealthTree Founder and CEO. "Unlike common clinical trial finders that allow patients to search for trials based on filters like zip code or treatment type, we are using tens of thousands of data points to ensure that patients receive personalized trial matches based on their real-world medical data."

"We are able to power the HealthTree Clinical Trial Finder with clean, validated and organized data thanks to our use of AI," said Juan Pablo Capdevila, HealthTree Chief Technology Officer. "This enables real-time analysis of the data against continuously updated trial databases for instant matching."

The HealthTree Clinical Trial Finder helps patients access all treatment options, saves search time for clinicians, and accelerates study enrollment, leading to the development of faster cures.

To use the HealthTree Clinical Trial Finder, join HealthTree Cure Hub.

This Blood Cancer Awareness Month, we are announcing enhancements to our multiple myeloma AI-powered Personalized Clinical Trial Finder and an expansion of the tool to include all blood cancers.

Enhancements to the tool include automated AI calculation of prior lines of therapy from patient medical records—an essential eligibility requirement that is difficult to determine from standard electronic health records. Additional improvements deliver higher perfect-match rates, clearer matching explanations and a patient feedback mechanism.

The HealthTree Clinical Trial Finder is now available for all blood cancers, including lymphomas, leukemias, and myeloproliferative neoplasms (MPNs).

This new feature uses artificial intelligence to match patients to clinical trials based on their individual medical records, increasing their chances of accessing cutting-edge therapies currently in development.

For many patients, finding an appropriate clinical trial can be an overwhelming and time-consuming process. Trial eligibility criteria are complex, and manually searching through hundreds of open trials is nearly impossible. Our Personalized Clinical Trial Finder streamlines this process by analyzing each patient's unique medical data—including lab values, treatment history, and disease markers—against the eligibility criteria of every available trial. The result is a curated list of trials for which the patient qualifies, helping them and their care teams make informed decisions about participation.

"This is the first truly personalized clinical trial finder," said Jenny Ahlstrom, HealthTree Founder and CEO. "Unlike common clinical trial finders that allow patients to search for trials based on filters like zip code or treatment type, we are using tens of thousands of data points to ensure that patients receive personalized trial matches based on their real-world medical data."

"We are able to power the HealthTree Clinical Trial Finder with clean, validated and organized data thanks to our use of AI," said Juan Pablo Capdevila, HealthTree Chief Technology Officer. "This enables real-time analysis of the data against continuously updated trial databases for instant matching."

The HealthTree Clinical Trial Finder helps patients access all treatment options, saves search time for clinicians, and accelerates study enrollment, leading to the development of faster cures.

To use the HealthTree Clinical Trial Finder, join HealthTree Cure Hub.

The author Leslie Fannon Zhang

about the author
Leslie Fannon Zhang

Leslie Fannon Zhang is a health and science writer and editor who joined HealthTree in 2025. She is passionate about making information about cancer and cancer care as accessible as possible. Leslie has written for the American Society of Clinical Oncology, the American Cancer Society, and the American Association for the Advancement of Science. 

Thanks to our sponsors:
Abbvie logo
newsletter icon

Get the Latest Blastic Plasmacytoid Dendritic Cell Neoplasm Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.